Vizimpro (Dacomitinib) is a prescription medication that used for the treatment of non-small lung cancer (NSCLC) that has spread to other parts of the body. This medication is used as the first treatment if your tumor has certain types of abnormal epidermal growth factor receptor (EGFR) genes. Dacomitinib belongs to the group of medications called protein-tyrosine-kinase inhibitor. This medication works by blocking the action of an abnormal protein that signals cancer cells to multiply, which helps slow or stop the cancer cells from spread. Vizimpro is usually taken once daily with or without food.
Our Online Canadian Pharmacy carries the brand Vizimpro from Canada manufactured by Pfizer. There is no generic available for this medication. Vizimpro is available in the strength of 15 mg, 30 mg and 45 mg tablets.
Vizimpro Side Effects
Inform your doctor if these side effects are severe or do not go away. The common side effects may include cough, difficulty sleeping, hair loss, infection of the skin around fingernails or toenails, lack of energy, loss of appetite, mouth sores, red or swollen eyes, taste changes, vomiting and weight loss.
Call your doctor immediately if you experience any of the serious side effects such as:
• Chest pain;
• Dry skin, acne, itchy skin, peeling or blistering of your skin, rash, redness;
• Shortness of breath, cough and fever
This is not a complete list of side effects and others may occur. Please call your doctor if you have any further concerns or questions.
You should not take Vizimpro if you are allergic to Dacomitinib or if you have any other allergies. Before you start taking this medication, talk to your doctor about your medical history and about all the medications you take including OTC and herbal medications. This medication may make you more sensitive to the sun. Limit your time in the sun. You should use sunscreen and wear protective clothing when you are outdoors. Inform your doctor right away if you have got sunburn or have skin blisters. Inform your doctor if you are pregnant or plan to become pregnant. This medication may harm an unborn baby. Use reliable forms of birth control while using this medication and for at least 17 days after stopping treatment. It is unknown if this medication passes into breast milk. Talk to your doctor before breast-feeding.